Nurse Practitioner · Rochester, MN
NPI
1093786568
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
200 1st St SW
Rochester, MN, 55905
Phone (507) 284-2511
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
845 services
Medicare patients, 2024
229
Average age 73
Drug cost, 2024
$1.2M
2,134 prescriptions
Company payments, 2024
$40.36
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sarah A Reiland was code 99214 (office e&m - established), 466 times for 215 patients. In total Sarah A Reiland billed 845 services in 15 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 466 | 215 | $80.67 | $38K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 305 | 179 | $11.03 | $3,363 |
| 95251 Test - Miscellaneous | Office | 17 | 17 | $23.81 | $405 |
| 99213 Office E&M - Established | Office | 14 | 14 | $46.65 | $653 |
By year: 2022 $35K for 509 services; 2023 $37K for 514 services; 2024 $45K for 845 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sarah A Reiland prescribed most often to Medicare patients was Ozempic (Semaglutide), with 324 prescriptions and refills. In total Sarah A Reiland wrote 2,134 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 324 | 397 | 64 | $360K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 225 | 580 | 74 | $31K |
| Mounjaro Tirzepatide | 103 | 126 | 19 | $135K |
| Trulicity Dulaglutide | 95 | 134 | 22 | $131K |
| Novolog Flexpen Insulin Aspart | 93 | 242 | 34 | $29K |
| Jardiance Empagliflozin | 86 | 184 | 25 | $107K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 85 | 212 | 26 | $41K |
| Metformin Hcl Er Metformin Hcl | 79 | 217 | 38 | $749 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 75 | 175 | 29 | $6,588 |
| Humalog Kwikpen U-100 Insulin Lispro | 73 | 155 | 28 | $17K |
| Metformin Hcl Generic | 61 | 148 | 21 | $653 |
| Farxiga Dapagliflozin Propanediol | 56 | 76 | 11 | $42K |
| Glimepiride Generic | 49 | 139 | 17 | $531 |
| Fiasp Flextouch Insulin Aspart (Niacinamide) | 46 | 102 | 13 | $39K |
| Novolin N Flexpen Insulin Nph Human Isophane | 44 | 103 | 14 | $7,012 |
Brand drugs: 1,619 claims; generic drugs: 303 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Sarah A Reiland $40.36 ($40.36 in general payments such as food, travel and fees) from 1 company. The largest payer was Insulet Corporation with $40.36.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 1 | $40.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.